InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by KELLY RALPH DAVID, Director. Director active across 1 companies, notably Invesco Real Estate Income Trust Inc.. In total, 2 disclosures have been logged. The latest transaction was disclosed on 1 December 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
02,683.766 shares0
Class E Common Stock, $0.01 par value
SEC:0001632674-25-000009·
02,683.766 shares0
Class E Common Stock, $0.01 par value
SEC:0001632674-25-000009:0·
2 of 2 declarations
About KELLY RALPH DAVID
Ralph David Kelly is the General Counsel at Akero Therapeutics, Inc. He oversees legal and regulatory matters, ensuring the company's compliance. His expertise is essential for managing legal risks.
